£160.00
Cream improves visible signs of ageing such as fine lines, wrinkles and loss of firmness.
2 in stock
Description
A.G.E. Interrupter is an advanced treatment that fights the visible signs of aging caused by Advanced Glycation End-products (A.G.E.). This anti-aging cream is formulated with an unprecedented 30% concentration of Proxylane™, 4% blueberry extract, and 0.2% phytosphingosine to help restore the loss of visible skin firmness caused by the glycation process. An integral part of any anti-aging skincare regimen to help prevent and correct visible signs of glycation.
- Improves the appearance of skin creping and thinning
- Reduces the appearance of fine lines, wrinkles, and rough texture
- Restores water and nutrients to improve the look of skin firmness
- Comforts dry, aging skin
Additional information
| Key Ingredients & Composition | 4% BLUEBERRY EXTRACT: NATURALLY DERIVED, BOTH AN ANTIOXIDANT AND ANTI-GLYCATION INGREDIENT HELPS FORTIFY SKIN’S MATRIX AND PREVENT THE APPEARANCE OF WRINKLES AND LAXITY 30% PROXYLANE™: DESIGNED TO HELP SUPPORT SKIN’S OWN G.A.G. SYNTHESIS AND RESTORE WATER AND NUTRIENTS TO SKIN 0.2% PHYTOSPHINGOSINE: A NATURALLY OCCURRING CHEMICAL FACILITATES SKIN’S NATURAL BARRIER REPAIR PROCESS AND HELPS PROTECT THE SKIN’S BARRIER BY ALLEVIATING THE DISCOMFORT ASSOCIATED WITH DRY, AGING SKIN 74079 37 – AQUA/WATER . PROPYLENE GLYCOL. DIMETHICONE. HYDROXYPROPYL TETRAHYDROPYRANTRIOL. CYCLOHEXASILOXANE. ISOHEXADECANE. GLYCERIN. SYNTHETIC WAX. DIMETHICONE/PEG-10/15 CROSSPOLYMER. ALUMINIUM STARCH OCTENYLSUCCINATE. PHENOXYETHANOL. MAGNESIUM SULFATE. CI 77163/BISMUTH OXYCHLORIDE. ETHYLHEXYL HYDROXYSTEARATE. SALICYLOYL PHYTOSPHINGOSINE. ACRYLATES COPOLYMER. METHYLPARABEN. ETHYLPARABEN. DISODIUM EDTA. SORBITOL. VACCINIUM MYRTILLUS FRUIT EXTRACT. DIPROPYLENE GLYCOL. SODIUM CITRATE. ISOBUTANE. PARFUM/FRAGRANCE. SILICA. TOCOPHEROL. COUMARIN. (F.I.L. Y293924/1) |
|---|---|
| How To Use | Once or twice daily, massage a thin, even layer of this anti-wrinkle cream onto the entire face, neck, and chest. |
